Kite Pharma was founded in 2009.
Kite Pharma was incorporated in the state of Delaware in June 2009.
2225 Colorado Avenue
Santa Monica, California 90404
Phone: (310) 824-9999
You can view our Board of Directors by visiting the Board of Directors section of our website.
You can view our management team by visiting the Management section of our website.
Ernst & Young LLP
Kite Pharma is traded on the NASDAQ stock exchange under the symbol “KITE”.
Kite Pharma went public on June 20, 2014.
Shares can be purchased through a stockbroker of your choice.
Kite Pharma does not offer a direct stock purchase plan.
Currently, Kite Pharma does not offer a dividend or a dividend reinvestment program.
49803L 10 9
Kite Pharma’s transfer agent is American Stock Transfer and Trust Company, LLC (AST). You can find more information about how to contact AST at: http://www.amstock.com/main/nav_contactUs.asp.
Please contact our transfer agent, American Stock Transfer, at: http://www.amstock.com/main/nav_contactUs.asp. The company can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.
You must send both your old and new addresses to our transfer agent, American Stock Transfer, http://www.amstock.com/main/nav_contactUs.asp, by U.S. mail. Each stockholder in question must sign the request for an address change.
Quarterly & Annual Reports and other investor materials are available under “Financials & Filings” of the “Investors” section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
You can view our recent press releases by visiting the Investor section of our website.
For media inquiries, please send an email to firstname.lastname@example.org.
You can view information on our platform and programs by visiting the Technology and Pipeline sections of our website.
For investor related questions, please send an email to email@example.com
Please email us at firstname.lastname@example.org
Please submit your question using the form below.